TY - JOUR AU - Yakubov A.V, AU - Saidova Sh.A., AU - Pulatova N.I., AU - Pulatova D.B., AU - Musayeva L.J, PY - 2023/01/11 Y2 - 2024/03/28 TI - Effectiveness of Liraglutide on Metabolic Risk Factors in Obesity Patients JF - Journal of Coastal Life Medicine JA - JCLM VL - 11 IS - 1 SE - Articles DO - UR - https://www.jclmm.com/index.php/journal/article/view/514 SP - 1314-1318 AB - <p>This article analyzes the effectiveness of Liraglutide and its impact on cardiometabolic risk factors in patients with obesity. The effectiveness of Victoza (liraglutide 3.0 mg) was studied in relation to changes in the mass index, body mass, body mass (BM), waist circumference (WC), blood pressure parameters and its effect on cardiometabolic factors. Сomplex therapy with the use of&nbsp; Liraglutide per day for 3 months is effective for the therapy of obesity and correction of obesity-associated cardiometabolic disturbances.&nbsp;</p> ER -